EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE 9600TFX26

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,foreig report with the FDA on 2020-03-31 for EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE 9600TFX26 manufactured by Edwards Lifesciences.

Event Text Entries

[185773953] The valve was not returned to edwards lifesciences for evaluation. Information regarding the disposition of the valve was not provided. The instructions for use (ifu) lists cardiovascular injury that may require intervention (including perforation or dissection of vessels, ventricle, myocardium or valvular structures, annular tear or rupture) as a potential risk associated with the overall tavr procedure. Aorto-cardiac or intra-cardiac fistulas and shunts are relatively rare but can result from endocarditis, tissue trauma or rupture of cardiac aneurysms. They have been reported as a rare complication following surgical or transcatheter aortic valve replacement. This type of defect in the cardiac tissues or aortic wall can result from trauma during percutaneous aortic valve implantation, additional in-valve balloon dilation on a heavily calcified native aortic valve, or tissue erosion over time from calcified vegetations or the valve frame. Percutaneous or surgical closure of para-prosthetic leaks may be required to close the communication. In this case, there was no allegation or indication a device malfunction contributed to this adverse event. Based on the information provided, the exact cause for the intra-cardiac, shunt and subsequent pericardial effusion is unknown but maybe be related to patient factors (calcification) or procedural factors (manipulation of devices). The ifu and training manuals have been reviewed and no inadequacies have been identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device. Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review. No corrective or preventative actions are required.
Patient Sequence No: 1, Text Type: N, H10


[185773974] As reported by edwards affiliate in (b)(6), during a transfemoral tavr procedure, post deployment of a 26mm sapien 3 valve in a? Very calcified valve? , an echo performed showed mild/moderate paravalvular leak (pvl). The decision was to post dilate the valve, however, the blood pressure of the patient dropped, and cardiac massage was required. An angiogram showed the patient had a small shunt between the left and the right ventricle. The decision was then made to deploy a second valve in a slightly lower position in order to fill the shunt. The patient remained unstable. A small tamponade was observed and drained, however the patient expired. It was confirmed that the shunt was visible right after the initial valve deployment.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2015691-2020-11245
MDR Report Key9904568
Report SourceCOMPANY REPRESENTATIVE,FOREIG
Date Received2020-03-31
Date of Report2020-03-10
Date of Event2020-03-10
Date Mfgr Received2020-03-10
Device Manufacturer Date2019-11-26
Date Added to Maude2020-03-31
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMRS. RENEE DORNE
Manufacturer Street1 EDWARDS WAY
Manufacturer CityIRVINE CA 92614
Manufacturer CountryUS
Manufacturer Postal92614
Manufacturer Phone9492506385
Manufacturer G1EDWARDS LIFESCIENCES LLC
Manufacturer StreetONE EDWARDS WAY
Manufacturer CityIRVINE CA 92614
Manufacturer CountryUS
Manufacturer Postal Code92614
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameEDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE
Generic NameAORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Product CodeNPT
Date Received2020-03-31
Model Number9600TFX26
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerEDWARDS LIFESCIENCES
Manufacturer AddressONE EDWARDS WAY IRVINE CA 92614 US 92614


Patients

Patient NumberTreatmentOutcomeDate
101. Death; 2. Required No Informationntervention 2020-03-31

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.